Maker Of $1,000 Hepatitis C Pill Looks To Cut Its Cost Overseas Law professor Brook Baker at Northeastern University in Boston, an adviser to Health Global Access Project, or Health GAP, notes that Gilead allows generic manufacturers to sell its HIV drugs in over 100 countries. “So why not a similarly large number of countries for the hepatitis C drug?” Baker tells Shots. “An important question to ask is what […]
Maker of $1,000 Hepatitis C pill looks to cut its cost overseas Law professor at Northeastern University in Boston, an adviser to , or Health GAP, notes that Gilead allows generic manufacturers to sell its HIV drugs in over 100 countries. “So why not a similarly large number of countries for the hepatitis C drug?” Baker tells Shots. “An important question to ask is what are their […]